“We’re pleased to support this important evolution of apabetalone and Resverlogix in its Phase 3 CORAL study,” said Kevin McDermott, Resverlogix Chief Commercial Officer, EVERSANA. “The EVERSANA COMPLETE Commercialization model is built to support customer needs by offering flexibility to quickly adapt development and launch strategies to meet market demands.”

Kevin McDermott, Resverlogix Chief Commercial Officer, EVERSANA.

A new name that we're seeing, or has someone seen his name before? He is one of three chief commercial officers with EVERSANA that I found, but who knows, there could be more.

Wondering if Marc Bernarducci moved on, or if he still is working with Resverlogix as well. He was Senior Vice President, Field Solutions...so it would be interesting to know why the new name appears, and if this is a downgrade?